To the full analysis
Abbott India stock: growth
ABBOTINDIA.NSAbbott India reported $736.48M in revenue for fiscal 2026, up 8.1% on the prior year, up 10% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
14.7%
per year from 2007 to 2026, per share 12.7%
Earnings (Annual rate)
18.7%
per year from 2007 to 2026, per share 16.6%
Free cash flow (Annual rate)
22.4%
per year from 2007 to 2026, per share 20.3%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2021 | since 2016 | since 2007 | |
|---|---|---|---|
| Revenue | 10.0% | 10.3% | 14.7% |
| Revenue per share | 10.0% | 10.3% | 12.7% |
| Earnings | 17.6% | 19.8% | 18.7% |
| Earnings per share | 17.6% | 19.8% | 16.6% |
| Free cash flow | 18.8% | 22.1% | 22.4% |
| Free cash flow per share | 18.8% | 22.1% | 20.3% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2007 | $54.23M | $6.36M | $3.82M |
| 2008 | $63.17M | $7.27M | $2.08M |
| 2009 | $70.76M | $6.68M | $6.99M |
| 2010 | $80.88M | $8.24M | $3.11M |
| 2011 | $105.21M | $6.48M | $3.61M |
| 2012 | $153.49M | $12.8M | $909.99K |
| 2013 | $171.1M | $15.38M | $8.94M |
| 2014 | $198.69M | $17.72M | $11.67M |
| 2015 | $237.65M | $24.34M | $20.91M |
| 2016 | $276.86M | $27.13M | $24.02M |
| 2017 | $307.46M | $29.4M | $30.37M |
| 2018 | $350.8M | $42.64M | $13.65M |
| 2019 | $390.67M | $47.87M | $51.72M |
| 2020 | $434.85M | $63.02M | $64.88M |
| 2021 | $457.85M | $73.41M | $74.77M |
| 2022 | $521.91M | $84.89M | $96.04M |
| 2023 | $568.3M | $100.91M | $91.33M |
| 2024 | $621.49M | $127.68M | $123.77M |
| 2025 | $680.99M | $150.34M | $101.96M |
| 2026 | $736.48M | $164.96M | $176.73M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 31 Mar 2026
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = ₹94.0836)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong, published since 7 Nov 2026 (in the score history since 18 Sep 2026)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.